Correlation Between Unicycive Therapeutics and Kiora Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Kiora Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Kiora Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and Kiora Pharmaceuticals, you can compare the effects of market volatilities on Unicycive Therapeutics and Kiora Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Kiora Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Kiora Pharmaceuticals.

Diversification Opportunities for Unicycive Therapeutics and Kiora Pharmaceuticals

0.08

Correlation Coefficient

Unicycive Therapeutics  Kiora Pharmaceuticals

Significant diversification

The 3 months correlation between Unicycive and Kiora is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Kiora Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiora Pharmaceuticals and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Kiora Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiora Pharmaceuticals has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Kiora Pharmaceuticals go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Kiora Pharmaceuticals

Given the investment horizon of 90 days Unicycive Therapeutics is expected to under-perform the Kiora Pharmaceuticals. In addition to that, Unicycive Therapeutics is 1.13 times more volatile than Kiora Pharmaceuticals. It trades about -0.07 of its total potential returns per unit of risk. Kiora Pharmaceuticals is currently generating about -0.02 per unit of volatility. If you would invest  330.00  in Kiora Pharmaceuticals on December 29, 2024 and sell it today you would lose (28.00) from holding Kiora Pharmaceuticals or give up 8.48% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Unicycive Therapeutics  vs.  Kiora Pharmaceuticals

Unicycive Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Unicycive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Kiora Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Kiora Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Kiora Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Unicycive Therapeutics and Kiora Pharmaceuticals

The main advantage of trading using opposite Unicycive Therapeutics and Kiora Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Kiora Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiora Pharmaceuticals will offset losses from the drop in Kiora Pharmaceuticals' long position.

The idea behind Unicycive Therapeutics and Kiora Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.